دورية أكاديمية

A Phase I Trial of a Methionine Restricted Diet with Concurrent Radiation Therapy.

التفاصيل البيبلوغرافية
العنوان: A Phase I Trial of a Methionine Restricted Diet with Concurrent Radiation Therapy.
المؤلفون: Mattes, Malcolm D., Koturbash, Igor, Leung, Calvin N., Wen, Sijin, Jacobson, Geraldine M.
المصدر: Nutrition & Cancer; 2024, Vol. 76 Issue 6, p463-468, 6p
مصطلحات موضوعية: AMINO acid metabolism, METHIONINE metabolism, PATIENT safety, RESEARCH funding, FOOD consumption, SKIN tumors, PILOT projects, CLINICAL trials, METHIONINE, TREATMENT effectiveness, DESCRIPTIVE statistics, METASTASIS, COMBINED modality therapy, MOLECULAR structure, BLOOD plasma, TUMORS, DIET therapy, DIET in disease, DIET, EVALUATION
مصطلحات جغرافية: UNITED States
مستخلص: Methionine is an essential amino acid critical for cell growth and survival. Preclinical evidence suggests a methionine restricted diet (MRD) sensitizes cancer to radiation therapy (RT), without significant adverse effects. However, this has never been evaluated in humans. The purpose of this pilot study was to evaluate the safety and feasibility of concurrent MRD with standard-of-care definitive RT in adults with any non-skin cancer malignancy. The MRD extended from 2 wk before RT initiation, through 2 wk beyond RT completion. The primary endpoint of safety was assessed as rate of grade 3 or higher acute and late toxicities. Feasibility was assessed with quantitative plasma amino acid panel every 2 wk during the MRD (target plasma methionine 13 μM). Nine patients were accrued over a two-year period, with five able to complete the treatment course. The trial was closed due to slow accrual and subjects' difficulty maintaining the diet. No grade 3 or higher adverse events were observed. Subjects' average methionine level was 18.8 μM during treatment, with average nadir 16.8 μM. These findings suggest the safety of concurrent MRD with RT, with toxicities comparable to those expected with RT alone. However, the diet was challenging, and unacceptable to most patients. [ABSTRACT FROM AUTHOR]
Copyright of Nutrition & Cancer is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:01635581
DOI:10.1080/01635581.2024.2340784